 The Center for Disease Control and Prevention CDC has added Paratek Pharmaceuticals Incs NASDAQ: PRTK antibiotic Nuzyra omadacycline as an alternative agent for pre-exposure prophylaxis and postexposure prophylaxis of primary bubonic and pharyngeal plague infections in adults 18 years of age and over. According to the CDC, Yersinia pestis Y. 